Skip to nav Skip to content

News

August 21, 2019

 ALL ARTICLES

Science Speaks Covers Ebola Treatment, Vaccination Developments

Data from a randomized trial of four investigational Ebola treatments showed significantly improved survival rates for two of the drugs. These findings offered hope that more lives can be saved and that access to effective medicine may encourage those with symptoms of the virus to seek earlier treatment. The findings, which led to the early termination of the treatment study, also demonstrated the feasibility of ethical research in the midst of an outbreak. But, as the IDSA/HIVMA global Science Speaks blog noted in its coverage of the results, barriers continue to stand between the treatment and the people who need it in the Democratic Republic of Congo – more than a year after the country’s 10th Ebola outbreak was recognized.

In addition, as Burundi became the fourth country bordering the epidemic-affected region of the DRC to launch an Ebola vaccination campaign among front-line health workers, Science Speaks covered the additional ongoing infectious disease challenges faced by the neighboring countries, highlighting critical needs for strengthened responses in the region.

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.